FOLFOX Alternated with FOLFIRI as First-Line Chemotherapy for Metastatic Colorectal Cancer-Reference-Cited by-同舟云学术

FOLFOX Alternated with FOLFIRI as First-Line Chemotherapy for Metastatic Colorectal Cancer

Published:2005-11 Issue:4 Volume:5 Page:263-267
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Aparicio Jorge,Fernández-Martos Carlos,Vicent Jose M.,Maestu Inmaculada,Llorca Christina,Busquier Isabel,Campos Jan M.,Pérez-Enguix Daniel,Balcells Miquel

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference22 articles.

1. Metastatic colorectal cancer: systemic treatment in the new millennium;Coutinho;Cancer Control,2003

2. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer;Saltz;N Engl J Med,2000

3. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial;Douillard;Lancet,2000

4. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;de Gramont;J Clin Oncol,2000

5. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study;Tournigand;J Clin Oncol,2004

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic characterization of the colorectal cancer response to chemoradiation and targeted therapies reveals potential therapeutic strategies;Cell Reports Medicine;2023-12

2. Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment?;World Journal of Gastrointestinal Oncology;2023-02-15

3. How to overcome tumor resistance to anti-PD-1/PD-L1 therapy by immunotherapy modifying the tumor microenvironment in MSS CRC;Clinical Immunology;2022-04

4. A clinically relevant heterozygous ATR mutation sensitizes colorectal cancer cells to replication stress;Scientific Reports;2022-03-31

5. Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer;OncoTargets and Therapy;2021-08